312 related articles for article (PubMed ID: 24411189)
21. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
22. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
23. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
24. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
25. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
[TBL] [Abstract][Full Text] [Related]
27. Thermal response and hyperthermic radiosensitization of scid mouse bone marrow CFU-C.
O'Hara MD; Pollard MD; Wheatley G; Regine WF; Mohiuddin M; Leeper DB
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):905-10. PubMed ID: 7860404
[TBL] [Abstract][Full Text] [Related]
28. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
Bauman G; Gete E; Chen JZ; Wong E
Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
[TBL] [Abstract][Full Text] [Related]
29. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
30. Thermoradiotherapy planning: Integration in routine clinical practice.
Crezee H; van Leeuwen CM; Oei AL; Stalpers LJ; Bel A; Franken NA; Kok HP
Int J Hyperthermia; 2016; 32(1):41-9. PubMed ID: 26670625
[TBL] [Abstract][Full Text] [Related]
31. Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose.
Li XA; Wang JZ; Stewart RD; Dibiase SJ; Wang D; Lawton CA
Br J Radiol; 2008 Jan; 81(961):59-68. PubMed ID: 18039721
[TBL] [Abstract][Full Text] [Related]
32. Experimental thermoradiotherapy in malignant hepatocellular carcinoma.
Hehr T; Budach W; Lamprecht U; Belka C; Classen J; Trübenbach J; Wehrmann M; Dietz K; Bamberg M
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1374-80. PubMed ID: 12654450
[TBL] [Abstract][Full Text] [Related]
33. Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy.
Xia T; Sun Q; Shi X; Fan N; Hiraoka M
Int J Clin Oncol; 2001 Jun; 6(3):138-42. PubMed ID: 11706783
[TBL] [Abstract][Full Text] [Related]
34. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia.
Ryu S; Brown SL; Kim SH; Khil MS; Kim JH
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):133-8. PubMed ID: 12118542
[TBL] [Abstract][Full Text] [Related]
35. Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
Kok HP; Korshuize-van Straten L; Bakker A; de Kroon-Oldenhof R; Geijsen ED; Stalpers LJA; Crezee J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):1039-1047. PubMed ID: 28870786
[TBL] [Abstract][Full Text] [Related]
36. Local hyperthermia of N2/N3 cervical lymph node metastases: correlationof technical/thermal parameters and response.
Wust P; Stahl H; Dieckmann K; Scheller S; Löffel J; Riess H; Bier J; Jahnke V; Felix R
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):635-46. PubMed ID: 8621288
[TBL] [Abstract][Full Text] [Related]
37. The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose.
van Leeuwen CM; Crezee J; Oei AL; Franken NAP; Stalpers LJA; Bel A; Kok HP
Int J Hyperthermia; 2018 Nov; 34(7):901-909. PubMed ID: 29749270
[TBL] [Abstract][Full Text] [Related]
38. The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients.
Schooneveldt G; Kok HP; Bakker A; Geijsen ED; Hulshof MCCM; Reijke TM; Crezee J
Int J Hyperthermia; 2018; 35(1):441-449. PubMed ID: 30303415
[TBL] [Abstract][Full Text] [Related]
39. Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients.
Kok HP; Herrera TD; Crezee J
Strahlenther Onkol; 2024 Jun; 200(6):512-522. PubMed ID: 38177701
[TBL] [Abstract][Full Text] [Related]
40. A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumours: a report of RTOG 89-08.
Myerson RJ; Scott CB; Emami B; Sapozink MD; Samulski TV
Int J Hyperthermia; 1996; 12(4):449-59. PubMed ID: 8877470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
